News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
496,079 Results
Type
Article (9956)
Company Profile (157)
Press Release (486062)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (171231)
Career Advice (366)
Deals (26335)
Drug Delivery (15)
Drug Development (54215)
Employer Resources (22)
FDA (9927)
Job Trends (8945)
News (243982)
Policy (18347)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (587)
Accelerated approval (21)
ADA (21)
Adcomms (1)
Allergies (98)
Alliances (34401)
ALS (107)
Alzheimer's disease (1003)
Antibody-drug conjugate (ADC) (293)
Approvals (10507)
Artificial intelligence (348)
ASCO (166)
Autoimmune disease (212)
Automation (32)
Bankruptcy (269)
Best Places to Work (7135)
BIO (41)
BIOSECURE Act (3)
Biosimilars (124)
BioSpace Insights (27)
Biotechnology (99)
Bladder cancer (138)
Brain cancer (33)
Breast cancer (514)
Cancer (3749)
Cardiovascular disease (222)
Career advice (295)
Career pathing (2)
CAR-T (186)
CDC (2)
Celiac Disease (1)
Cell therapy (519)
Cervical cancer (38)
Clinical research (48747)
Collaboration (1341)
Commercialization (2)
Company closure (3)
Compensation (1413)
Complete response letters (35)
COVID-19 (886)
CRISPR (69)
C-suite (799)
Cystic fibrosis (89)
Data (5694)
Denatured (10)
Depression (110)
Dermatology (61)
Diabetes (351)
Diagnostics (4303)
Digital health (37)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (180)
Drug pricing (16)
Drug shortages (2)
Duchenne muscular dystrophy (182)
Earnings (73811)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (89124)
Executive appointments (738)
FDA (12529)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (1030)
Gene editing (142)
Generative AI (12)
Gene therapy (351)
GLP-1 (343)
Government (1051)
Grass and pollen (2)
Guidances (284)
Healthcare (9514)
Hematology (95)
HIV (54)
Huntington's disease (24)
IgA nephropathy (63)
Immunology and inflammation (133)
Immuno-oncology (68)
Indications (154)
Infectious disease (1088)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (88)
Intellectual property (255)
Interviews (46)
IPO (12582)
IRA (7)
Job creations (2139)
Job search strategy (281)
JPM (5)
Kidney cancer (19)
Labor market (12)
Layoffs (105)
Leadership (3)
Legal (5279)
Licensing (2)
Liver cancer (48)
Longevity (18)
Lung cancer (513)
Lymphoma (252)
Machine learning (30)
Management (7)
Manufacturing (557)
Marketing (7)
MASH (120)
Medical device (8733)
Medtech (8862)
Mergers & acquisitions (14774)
Metabolic disorders (740)
mRNA (61)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (234)
Neuropsychiatric disorders (47)
Neuroscience (1894)
NextGen: Class of 2026 (3339)
Non-profit (956)
Now hiring (15)
Obesity (245)
Opinion (30)
Ovarian cancer (160)
Pain (175)
Pancreatic cancer (207)
Parkinson's disease (207)
Partnered (14)
Patents (473)
Patient recruitment (504)
Peanut (32)
People (42790)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15889)
Phase 2 (21842)
Phase 3 (14711)
Pipeline (6952)
Policy (33)
Postmarket research (1579)
Preclinical (6721)
Press Release (34)
Prostate cancer (189)
Psychedelics (12)
Radiopharmaceuticals (197)
Rare diseases (605)
Real estate (3254)
Recruiting (10)
Regulatory (15107)
Reports (20)
Research institute (681)
Resumes & cover letters (52)
Rett syndrome (39)
RNA editing (8)
RSV (49)
Schizophrenia (108)
Series A (187)
Series B (137)
Service/supplier (4)
Sickle cell disease (64)
Special edition (3)
Spinal muscular atrophy (88)
Sponsored (6)
Startups (2287)
Stomach cancer (5)
Supply chain (52)
Tariffs (2)
The Weekly (6)
Vaccines (356)
Venture capital (36)
Weight loss (94)
Women's health (80)
Worklife (1)
Date
Today (13)
Last 7 days (367)
Last 30 days (1178)
Last 365 days (19827)
2026 (11561)
2025 (20000)
2024 (23634)
2023 (27239)
2022 (35532)
2021 (38238)
2020 (34507)
2019 (24026)
2018 (18150)
2017 (19377)
2016 (18548)
2015 (24829)
2014 (22070)
2013 (18600)
2012 (20697)
2011 (20858)
2010 (20701)
Location
Africa (250)
Alabama (75)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (18995)
Australia (2284)
California (11925)
Canada (3117)
China (567)
Colorado (474)
Connecticut (405)
Delaware (208)
Europe (27239)
Florida (1752)
Georgia (367)
Hawaii (4)
Idaho (47)
Illinois (709)
India (47)
Indiana (319)
Iowa (13)
Japan (399)
Kansas (109)
Kentucky (31)
Louisiana (27)
Maine (25)
Maryland (1182)
Massachusetts (7850)
Michigan (305)
Minnesota (560)
Mississippi (5)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (113)
New Hampshire (63)
New Jersey (2609)
New Mexico (12)
New York (2775)
North Carolina (1259)
North Dakota (4)
Northern California (5968)
Ohio (282)
Oklahoma (15)
Oregon (18)
Pennsylvania (2223)
Puerto Rico (21)
Rhode Island (31)
South America (424)
South Carolina (75)
South Dakota (1)
Southern California (4907)
Tennessee (119)
Texas (1918)
United States (38638)
Utah (355)
Vermont (1)
Virginia (153)
Washington D.C. (41)
Washington State (957)
West Virginia (2)
Wisconsin (84)
496,079 Results for "alamar biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
July 28, 2026
·
5 min read
Press Releases
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
July 14, 2026
·
1 min read
Press Releases
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
July 13, 2026
·
6 min read
Press Releases
Alamar Biosciences Reports First Quarter 2026 Financial Results
May 8, 2026
·
8 min read
Press Releases
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
May 6, 2026
·
1 min read
Press Releases
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
July 10, 2026
·
5 min read
Press Releases
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
July 7, 2026
·
6 min read
Press Releases
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
March 17, 2026
·
4 min read
Press Releases
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
January 12, 2026
·
3 min read
Press Releases
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
January 13, 2026
·
2 min read
1 of 49,608
Next
